Literature DB >> 760802

Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.

G J Arlaud, A Reboul, R B Sim, M G Colomb.   

Abstract

1. Insoluble IgG-ovalbumin aggregates were used to bind and activate C1 from human serum. The bound C1 provided a useful reagent for studying the interaction of C1 subcomponents with C1-inhibitor. 2. C1-inhibitor bound to both subcomponents (C1r and C1s in C1 and formed stable complexes of respective apparent molecular weights 197,000 and 185,000, as determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. The binding reaction proceeded more readily with C1s than with C1r and was correlated with the inhibition of C1s esterase activity. 3. At physiological ionic strength, binding of C1-inhibitor to subcomponents C1r and C1s caused release of these subcomponents from the C1-immune aggregates complex, indicating that C1-inhibitor binding decreased the inter-subcomponent binding forces in C1. At low ionic strength, however, this release did not occur.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760802     DOI: 10.1016/0005-2795(79)90494-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

2.  Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.

Authors:  S J Perkins
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

3.  C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.

Authors:  R B Sim; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

4.  C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.

Authors:  G Doekes; L A van Es; M R Daha
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

Review 5.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994

6.  Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.

Authors:  M A Smith; M A Kerr
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

7.  3D artificial round section micro-vessels to investigate endothelial cells under physiological flow conditions.

Authors:  Riccardo Sfriso; Shengye Zhang; Colette Andrea Bichsel; Oliver Steck; Alain Despont; Olivier Thierry Guenat; Robert Rieben
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

8.  An association study of SERPING1 gene and age-related macular degeneration in a Han Chinese population.

Authors:  Fang Lu; Peiquan Zhao; Yinchuan Fan; Shibo Tang; Jianbin Hu; Xiaoqi Liu; Xian Yang; Yiye Chen; Tao Li; Chuntao Lei; Jiyun Yang; Ying Lin; Shi Ma; Chunyong Li; Yi Shi; Zhenglin Yang
Journal:  Mol Vis       Date:  2010-01-10       Impact factor: 2.367

9.  The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin.

Authors:  Christine Gaboriaud; Rajesh Kumar Gupta; Lydie Martin; Monique Lacroix; Laurence Serre; Florence Teillet; Gérard J Arlaud; Véronique Rossi; Nicole M Thielens
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.